Posts for Ticker ‘ELN’

Top 10 Analyst Upgrades, Downgrades, Initiations (MT, BMRN, ELN, FITB, FSLR, GCI, GT, HAL, PVTB, URBN)

These are this Thursday morning’s top 10 analyst upgrades, downgrades, and initiations we have seen in early research calls from Wall Street:

ArcelorMittal (NYSE: MT) Raised to Buy at Societe Generale.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Raised to Outperform at Credit Suisse.
Elan Corp. plc (NYSE: ELN) Cut to Neutral at UBS.
Fifth Third Bancorp Raised To Outperform From Neutral By Baird
First Solar Inc. (NASDAQ: FSLR) Cut to Neutral at BofA/Merrill.
Gannett Co. (NYSE: GCI) Cut to Underperform at Wells Fargo.
Goodyear Tire (NYSE: GT) Cut to Underperform at BofA/Merrill.
Halliburton Co. (NYSE: HAL) Started as Outperform at Wells Fargo.
PrivateBancorp Inc. (NASDAQ: PVTB) Cut to Neutral at JPMorgan.
Urban Outfitters (NASDAQ: URBN) Raised to Overweight at Thomas Weisel.

You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG

The Next Blockbuster Drugs: A $170 Billion Opportunity

biotech

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market.

With help from Thomson Pharma and our own backlog of coverage, BioHealthInvestor.com, a 247wallst.com website, sought to find the most promising biopharmaceutical candidate from both biotech and pharmaceutical companies in each of the top 10 most prevalent medical conditions in the U.S. Read More »

Top Analyst Upgrades and Downgrades (AGN, BJS, CTRN, ELN, ENDP, MVL, BTU, TXN, TXRH, TSN)

These are the top 10 analyst upgrades and downgrades we have seen from Wall Street firms early this Monday morning:

  • Allergan (AGN) Raised to Buy at Citigroup.
  • BJ Services (BJS) Cut to Underperform at Wells Fargo.
  • Citi Trends (CTRN) Cut to Neutral at JPMorgan.
  • Elan (ELN) Raised to Buy at UBS.
  • Endo Pharmaceuticals (ENDP) Started as Buy at Citigroup.
  • Marvel Entertainment (MVL) Cut to Neutral at Janney
  • Peabody Energy (BTU) Raised to Outperform at FBR.
  • Texas Instruments (TXN) Raised to Hold from Underperform at Jefferies; Reiterated Sell w/ $14 target at Auriga.
  • Texas Roadhouse (TXRH) Cut to Neutral at Baird.
  • Tyson Foods (TSN) Cut to Hold at Deutsche Bank.

Jon C. Ogg
July 20, 2009

Top Analyst Upgrades (STD, DVN, ELN, RIMM, TJX, VOD)

These are some of the top pre-market analyst upgrades and positive research calls we have seen early this Friday morning:

Banco Santander (STD) Raised to Outperform at KBW.
Devon Energy (DVN) Raised to Outperform at FBR.
Elan (ELN) Raised to Neutral from Sell at Piper Jaffray.
Research in Motion (RIMM) Raised to Hold at Deutsche Bank; Raised to Outperform at CIBC; estimates and price targets adjusted higher by at least 5 other firms so far this morning.
TJX Cos. (TJX) Started as Outperform at RBC.
Vodafone (VOD) Raised to Outperform at Credit Suisse.

JON C. OGG

S&P Cuts Ireland; Financial Potato Famine (IRE, AIB, IRL, ELN)

burning-money-pic39It is not very frequent that you see an English-speaking country take a sovereign credit ratings agency downgrade.  That would  indicate the government is one step farther away from being able to repay its debt.  It has happened in Eastern Europe and selectively in the European Union, but today a sovereign credit rating cut from Standard & Poor’s made its way to Ireland.
Read More »

Early Bird Analyst Upgrades (ATML, ELN, FDP, ICLR, SLW, SMA)

Money_stack_picThese are some of the top pre-market analyst upgrades from Wall Street which we have seen this Tuesday morning with more than two hours until the open:

  • Atmel (NASDAQ: ATML) Started as Buy at Goldman Sachs.
  • Elan (NYSE: ELN) Raised to Buy at Canaccord.
  • Fresh Del Monte (NYSE: FDP) Started as Buy at Jefferies.
  • Icon (NASDAQ: ICLR) Raised to Buy at Goldman Sachs.
  • Silver Wheaton (NYSE: SLW) Raised to Buy at UBS.
  • Symmetry Medical (NYSE: SMA) Raised to Market Perform at Wachovia.

Jon C. Ogg
January 13, 2009

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Tysabri_logoBiogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies were notified of a confirmed case of progressive multifocal leukoencephalopathy.  In other words, it found another PML case in a multiple sclerosis patient treated with TYSABRI. This is also affecting shares of its partner Elan Corp. plc (NYSE: ELN).

Read More »

Top Pre-Market Analyst Upgrades & Downgrades (ELN, ESLT, LLNW, RDC, SLW, AIG, EAT, ENTR, HNT, INAP, NVS, OEH, PACR, TI )

Upgrades and Positive Calls:

  • Elan (ELN) Raised to Equal-weight at Lehman.
  • Elbit Systems (ESLT) Raised to Buy at UBS.
  • Limelight Networks (LLNW) Raised to Buy at Jefferies.
  • Rowan Cos. (RDC) Raised to Buy at Jefferies.
  • Silver Wheaton (SLW) Raised to Outperform at Raymond James.

Downgrades or Cautious Calls:

  • American International Group (AIG) Started as Sell at Societe Generale.
  • Brinker (EAT) Cut to Neutral at UBS.
  • Entropic Communications (ENTR) Cut to Neutral at Merriman Curhan Ford.
  • Health Net (HNT) Cut to Hold at Citigroup.
  • Internap (INAP) Cut to Perform at Oppenheimer.
  • Novartis (NVS) Cut to Neutral at JPMorgan.
  • Orient Express (OEH) Cut to Neutral at UBS.
  • Pacer International (PACR) Cut To Underweight at JPMorgan.
  • Telecom Italia (TI) Cut to Neutral at Goldman Sachs.

Jon C. Ogg
August 6, 2008

The 52-Week Low Club (ELN)(GHS)(GFI)(CBS)(TOMO)(BIIB)

Sad_clownElan Corporation (ELN) Problems with one of the company’s major drugs. Falls to $9.55 from 52-week high of $37.45.

Gatehouse (GHS) More poor newspaper earnings raise issue of whether company is viable. Falls to $.48 from 52-week high of $17.43.

Gold Fields (GFI) Tough earnings and COO out. Off to $9.98 from 52-week high of $19.92

Read More »

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

Tysabri_logoThis morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe.  We do not want to try to sound as though this TYSABRI news is something that isn’t of consequence and don’t want to make it sound like it is a non-event.  Last night after the close the companies released the bad news that two more PML cases had been discovered in TYSABRI patients using the drug for the treatment of Multiple Sclerosis.

Read More »

Top 10 Pre-Market Analyst Calls (DD, ELN, LOGI, MSFT, OMPI, PDLI, RRGB, RMG, WHR, XFML )

These are not all of the analyst calls moving stocks this morning, but these are the top ten individual analyst calls that 247WallSt.com is focusing on this morning:

  • DuPont (NYSE: DD) started as Outperform at Credit Suisse.
  • Elan (NYSE: ELN) started as Outperform at Credit Suisse.
  • Logitec (NASDAQ: LOGI) started as Buy at Citigroup.
  • Microsoft (NASDAQ: MSFT) started as Buy at Jefferies.
  • Obagi Medical (NASDAQ: OMPI) raised to Outperform at Oppenheimer.
  • PDL BioPharma (NASDAQ: PDLI) cut to Equal-Weight at Lehman Brothers.
  • Red Robin Gourmet Burgers (NASDAQ: RRGB) raised to Overweight at JP Morgan.
  • RiskMetrics Group (NYSE: RMG) started as Outperform at Credit Suisse; started as Neutral at Banc of America.
  • Whirlpool (NYSE: WHR) downgraded to Underweight at JPMorgan.
  • Xinhua Financial Media (NASDAQ: XFML) downgraded to Neutral at JP Morgan.

Jon C. Ogg
March 5, 2008

Top Pre-Market Stock News (January 7, 2008)

Below is a snapshot of some of the key impact news affecting stocks in pre-market trading this Monday, January 7, 2008:

  • AllianceBernstein (AB) noted as a hidden gem in Barron’s cover story.
  • Answers Corp. (ANSW) announced a collaboration with Nokia for Series 40 and S60 mobile devices.
  • Avocet (AVCT) lowered guidance
  • Biogen-Idec (BIIB) and Elan (ELN) say that the safety data continues to support a favorable benefit-risk profile for TYSABRI.
  • Celgene Corp. (CELG) trading up 5% after guidance is in-line for 2007 and issued new guidance for 2008.
  • CNET (CNET) had a Jana Partners-led investor group take a 21% stake and try to oust the board of directors.
  • Diana Shipping (DSX) trading up almost 2% on positive Barron’s article over weekend.
  • 8X8 Inc. (EGHT) introduced a free international mobile calling plan with its new Packet8 MobileTalk trial.
  • hhgregg (HGG) reaffirmed 2008 EPS guidance of $0.95 to $1.03 vs. $1.00 est.; s-s-s up 3%.
  • JA Solar (JASO) announced a 3 for 1 stock split.
  • Jefferies (JEF) issued earnings warning.
  • Krispy Kreme (KKD) announced it has elected a new CEO.
  • Microsoft (MSFT) said at "CES" it had 100 million licenses sold of Windows Vista; 17.7 million Xbox 360’s, 10 million Xbox live users; will have new content downloads.
  • Napster (NAPS) will sell music with less copyright protection as MP3 files.
  • Nice Systems (NICE) received multi-million dollar orders from 2 of the top-3 US banks for fraud alert.
  • Rogers Communications (RCI) raised annual dividend from $0.50 to $1.00 and put 2008 revenues $11.2 to $11.5 Billion versus $11.25 Billion estimates; announced share buyback.
  • Schnitzer Steel (SCHN) missed earnings and revenue targets; stock trading down 1% so far.
  • Sony (SNE) introduces new tri-recording video Camcorder at "CES".
  • TASER (TASR) unveils its new leopard print TASER C2 personal protection device at the 2008 International Consumer Electronic tradeshow in Las Vegas today.
  • Zumiez (ZUMZ) said December s-s-s was +3.9%, but guided lower; shares down over 1%.

Jon C. Ogg
January 7, 2007

Pre-Market Analyst Calls (October 2, 2007)

ACAD started as Hold at Citigroup.
ALB raised to Neutral at Goldman Sachs.
AMB raised to Buy at B of A.
APD cut to Neutral at Goldman Sachs.
BAC started as Buy at Goldman Sachs.
BDN cut to Neutral at B of A.
BIIB cut to Underperform at Credit Suisse.
BRLC cut to Neutral at R.W.Baird.
CBS cut to Hold at Deutsche Bank.
CNH cut to Neutral at Goldman Sachs.
CYPB started as Outperform at FBR.
ELN started as Underperform at FBR.
FRX raised to Hold at Citigroup.
MDCO raised to Buy at UBS.
MON removed from Goldman Sachs Conviction Buy List.
MPG cut to Sell at B of A.
NOK cut to Mkt Perform at JMP Securities.
NVT raised to Hold at Deutsche Bank (ooops); cut to Neutral at UBS.
ONXX cut to Peer Perform at at Bear Stearns.
PDLI raised to Outperform at Wachovia.
PLD raised to Buy at B of A.
RATE cut to Neutral at Merriman Curhan Ford.
SLG cut to Neutral at B of A.
STEI started as Buy at B of A.
UBS raised to Neutral at JPMorgan.
VAL cut to Sell at Goldman Sachs.
WAG cut to Neutral at Goldman Sachs (late Monday call); cut to Neutral at Merrill Lynch.

Jon C. Ogg
October 2, 2007

Pre-Market Stock News (May 21, 2007)

(ASD) American Standard is reaffirming guidance.
(AT) Alltel agreed to a $27.5 Billion buyout offer, or $71.50 per share.
(CATT) Catapult believes it will miss its earnings estimates for the quarter.
(CRM) Salesforce.com in talks for another technology integration pact with Google.
(CYTC) Cytyc being acquired by Hologic for $46.46 in cash and stock; stock up almost 30%.
(DNDN) Dendreon announces presentation of data at American Urological Association annual meeting; stock up 8%.
(EAGL) EGL announced that CEVA Group increased its offer to $47.50.
(ELN) Elan and Wyeth are starting Phase III clinical trial of Bapineuzumab in Alzheimer’s disease.
(FBN) Furniture Brands CFO is leaving to join ITT.
(GE) GE’s plastics unit sale could be announced as soon as today.
(GRRF) China Grentech announced its first bulk production order to supply TD-SCDMA RF power amplifier modules
(KO) Coca-Cola’s CEO was named the final transformational CEO by Cramer.
(NCTY) The9Ltd. in pact for sports games with Electronic Arts.
(NHY) Norsk Hydro is selling its polymers group.
(PFE) Pfizer CFO is leaving; head of R&D is retiring.
(PONR) Pioneer Companies being acquired for $35.00 per share in cash by Olin (OLN).
(QTWW) Quantum Fuel awarded diesel hybrid vehicle pact from US Army.
(RTLX) Retalix $0.09 EPS vs -$0.01e; unsure if comparable.
(TSL) Trina Solar $0.22 EPS vs $0.15e.

Jon C. Ogg
May 21, 2007